luc2 luciferase Search Results


90
Developmental Studies Hybridoma Bank luc2
Antibodies
Luc2, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/pmc07306043-6-2-8?v=Developmental+Studies+Hybridoma+Bank
Average 90 stars, based on 1 article reviews
luc2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Addgene inc parabad pet
Antibodies
Parabad Pet, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/silverman_bradley_ross__2020__protein_mediated_colloidal_assembly-694-38-43?v=Addgene+inc
Average 90 stars, based on 1 article reviews
parabad pet - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Promega pgl4.41[luc2p/hse/hygro] plasmid hse-luc
Antibodies
Pgl4.41[Luc2p/Hse/Hygro] Plasmid Hse Luc, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/pmc09519049-254-1-4?v=Promega
Average 90 stars, based on 1 article reviews
pgl4.41[luc2p/hse/hygro] plasmid hse-luc - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare luciferase-tagged mouse mammary cancer cell line 4t1-luc2
Antibodies
Luciferase Tagged Mouse Mammary Cancer Cell Line 4t1 Luc2, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/pmc10369066-47-0-14?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
luciferase-tagged mouse mammary cancer cell line 4t1-luc2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
clea japan inc pk-9 cells expressing luciferase pk-9-td tomato-luc2
Antibodies
Pk 9 Cells Expressing Luciferase Pk 9 Td Tomato Luc2, supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/us11203615-145-31-54?v=clea+japan+inc
Average 90 stars, based on 1 article reviews
pk-9 cells expressing luciferase pk-9-td tomato-luc2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
biolasco taiwan hcclm3_luc2 tumor stably expressing firefly luciferase
Antibodies
Hcclm3 Luc2 Tumor Stably Expressing Firefly Luciferase, supplied by biolasco taiwan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/pm25624051-104-17-7?v=biolasco+taiwan
Average 90 stars, based on 1 article reviews
hcclm3_luc2 tumor stably expressing firefly luciferase - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
GenScript corporation luciferase gene luc-2
Antibodies
Luciferase Gene Luc 2, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/us10081812-368-31-35?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
luciferase gene luc-2 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Trenzyme Inc luciferase (luc2) gene
Levels of inflammatory markers measured in plasma of sham and 1.5 × 10 6 ·ml −1 of <t> MRMT‐1/Luc2‐bearing </t> animals
Luciferase (Luc2) Gene, supplied by Trenzyme Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/luc2+luciferase/pmc08246843-80-20-23?v=Trenzyme+Inc
Average 90 stars, based on 1 article reviews
luciferase (luc2) gene - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

Image Search Results


Antibodies

Journal: Cell and Tissue Research

Article Title: Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury

doi: 10.1007/s00441-020-03173-1

Figure Lengend Snippet: Antibodies

Article Snippet: Primary , Luc2 , Mouse , monoclonal , DSHB , DSHB-LUC-2 , Cytoplasm , 25:100 , Luc2-copGFP transduced cells.

Techniques: Control

In vitro differentiation and loading with ferumoxytol of transduced HFBSCs. Prior to differentiation (day − 1) pCDH-EF1α-Luc2-T2A-copGFP-transduced cells exhibited a bright green-fluorescent signal of copGFP (a) and had normal morphologies (a″; phase contrast). The merged image (a‴) demonstrates that all cells were transduced with the reporter gene construct. Within 7 days, HFBSCs adapted neuronal morphologies (b; copGFP fluorescence and b′; Phase contrast). Scale bar is 100 μm. HFBSCs transduced with the pCDH-DCX-Luc2-T2A-copGFP construct did not express copGFP (or Luc2) prior to differentiation (day − 1) as indicated by the absence of a fluorescent signal (c). However, cells expressed copGFP under regulation of the DCX promoter as indicated by the green fluorescent signal 7 days after start of the differentiation (d). HFBSCs also adapted neuronal morphologies (d′; phase contrast). Scale bar is 100 μm. Perls’ Prussian blue (PB) staining + DAB intensification stained ferumoxytol within the cells as marked by a brown precipitate (e′). Faint copGFP fluorescence persisted through the staining process as can be observed in the fluorescence (e) and merged images (e″). Scale bar is 100 μm

Journal: Cell and Tissue Research

Article Title: Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury

doi: 10.1007/s00441-020-03173-1

Figure Lengend Snippet: In vitro differentiation and loading with ferumoxytol of transduced HFBSCs. Prior to differentiation (day − 1) pCDH-EF1α-Luc2-T2A-copGFP-transduced cells exhibited a bright green-fluorescent signal of copGFP (a) and had normal morphologies (a″; phase contrast). The merged image (a‴) demonstrates that all cells were transduced with the reporter gene construct. Within 7 days, HFBSCs adapted neuronal morphologies (b; copGFP fluorescence and b′; Phase contrast). Scale bar is 100 μm. HFBSCs transduced with the pCDH-DCX-Luc2-T2A-copGFP construct did not express copGFP (or Luc2) prior to differentiation (day − 1) as indicated by the absence of a fluorescent signal (c). However, cells expressed copGFP under regulation of the DCX promoter as indicated by the green fluorescent signal 7 days after start of the differentiation (d). HFBSCs also adapted neuronal morphologies (d′; phase contrast). Scale bar is 100 μm. Perls’ Prussian blue (PB) staining + DAB intensification stained ferumoxytol within the cells as marked by a brown precipitate (e′). Faint copGFP fluorescence persisted through the staining process as can be observed in the fluorescence (e) and merged images (e″). Scale bar is 100 μm

Article Snippet: Primary , Luc2 , Mouse , monoclonal , DSHB , DSHB-LUC-2 , Cytoplasm , 25:100 , Luc2-copGFP transduced cells.

Techniques: In Vitro, Transduction, Construct, Fluorescence, Staining

Observation of Luc2 activity in TBI mice in vivo. Representative overlays of pCDH-EF1α-Luc2-T2A-copGFP-transduced HFBSCs from 2 (a), 14 (a′), 33 (a″) and 49 days after transplantation (a‴). The bioluminescent signal increased with relative stability over the course of time. Representative overlays of HFBSCs transduced with pCDH-DCX-Luc2-T2A-copGFP over the same period of time. No bioluminescent signal was observed 2 days after transplantation (b). The signal increased between 14 days (b′) and 33 days (b″) but was almost undetectable after 49 days (b‴). Analysis of the bioluminescent signal was measured 2, 14, 33 and 49 days after transplantation (c). The bioluminescence data were normalized with the initial signal and measured 2 days after transplantation, which depicts the trend of the bioluminescent signal from HFBSCs over time. The bioluminescent signal of pCDH-EF1α-Luc2-T2A-copGFP-transduced HFBSCs increased steadily over the course of time, while the bioluminescence of pCDH-DCX-Luc2-T2A-copGFP-transduced HFBSCs decreased after 33 days and was almost undetectable at 49 days

Journal: Cell and Tissue Research

Article Title: Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury

doi: 10.1007/s00441-020-03173-1

Figure Lengend Snippet: Observation of Luc2 activity in TBI mice in vivo. Representative overlays of pCDH-EF1α-Luc2-T2A-copGFP-transduced HFBSCs from 2 (a), 14 (a′), 33 (a″) and 49 days after transplantation (a‴). The bioluminescent signal increased with relative stability over the course of time. Representative overlays of HFBSCs transduced with pCDH-DCX-Luc2-T2A-copGFP over the same period of time. No bioluminescent signal was observed 2 days after transplantation (b). The signal increased between 14 days (b′) and 33 days (b″) but was almost undetectable after 49 days (b‴). Analysis of the bioluminescent signal was measured 2, 14, 33 and 49 days after transplantation (c). The bioluminescence data were normalized with the initial signal and measured 2 days after transplantation, which depicts the trend of the bioluminescent signal from HFBSCs over time. The bioluminescent signal of pCDH-EF1α-Luc2-T2A-copGFP-transduced HFBSCs increased steadily over the course of time, while the bioluminescence of pCDH-DCX-Luc2-T2A-copGFP-transduced HFBSCs decreased after 33 days and was almost undetectable at 49 days

Article Snippet: Primary , Luc2 , Mouse , monoclonal , DSHB , DSHB-LUC-2 , Cytoplasm , 25:100 , Luc2-copGFP transduced cells.

Techniques: Activity Assay, In Vivo, Transplantation Assay, Transduction

Immunohistochemical staining of HFBSCs constitutively expressing Luc2 and copGFP. Sections of mouse brains containing transduced HFBSCs exhibited native green fluorescence emitted by copGFP after fixation, sectioning and staining of the sections (a, b, c, d; green). Sections containing copGFP-expressing HFBSCs were stained for either copGFP (a′ and c′) or Luc2 (b′ and d′). CopGFP-expressing HFBSCs stained for copGFP (a′; red) and the neural progenitor cell marker nestin (a″; gray). The merged image (a′′′′) shows colocalization of copGFP (a′), nestin (a″) and DNA (a‴) of copGFP-expressing HFBSCs in the mouse brain. HFBSCs, which expressed copGFP (b; green), also stained for Luc2 (b′; red). GFAP (b″; gray) stained in the mouse brain but is absent in HFBSCs (b‴; green/red). Transplanted HFBSCs (c/c′; green/red) stained for NF-Pan (c″; gray). None of the copGFP-expressing HFBSCs (d/d′; green/red) stained for DCX (d″). Scale bar = 50 μm

Journal: Cell and Tissue Research

Article Title: Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury

doi: 10.1007/s00441-020-03173-1

Figure Lengend Snippet: Immunohistochemical staining of HFBSCs constitutively expressing Luc2 and copGFP. Sections of mouse brains containing transduced HFBSCs exhibited native green fluorescence emitted by copGFP after fixation, sectioning and staining of the sections (a, b, c, d; green). Sections containing copGFP-expressing HFBSCs were stained for either copGFP (a′ and c′) or Luc2 (b′ and d′). CopGFP-expressing HFBSCs stained for copGFP (a′; red) and the neural progenitor cell marker nestin (a″; gray). The merged image (a′′′′) shows colocalization of copGFP (a′), nestin (a″) and DNA (a‴) of copGFP-expressing HFBSCs in the mouse brain. HFBSCs, which expressed copGFP (b; green), also stained for Luc2 (b′; red). GFAP (b″; gray) stained in the mouse brain but is absent in HFBSCs (b‴; green/red). Transplanted HFBSCs (c/c′; green/red) stained for NF-Pan (c″; gray). None of the copGFP-expressing HFBSCs (d/d′; green/red) stained for DCX (d″). Scale bar = 50 μm

Article Snippet: Primary , Luc2 , Mouse , monoclonal , DSHB , DSHB-LUC-2 , Cytoplasm , 25:100 , Luc2-copGFP transduced cells.

Techniques: Immunohistochemical staining, Staining, Expressing, Fluorescence, Marker

Immunohistochemical staining for extracellular matrix and proliferating cells. CopGFP-expressing HFBSCs in mouse brain sections exhibited native fluorescence (a, b, and c; copGFP protein; green). Additionally, sections were stained for Luc2 (a′, b′, and c′; red). The surrounding area of some HFBSCs stained for fibronectin (a″; gray). The vicinity of transplanted HFBSCs stained for laminin (b″; gray). Staining for Ki-67 (c″; gray) was negative in sections containing HFBSCs (green/red). Scale bar = 50 μm

Journal: Cell and Tissue Research

Article Title: Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury

doi: 10.1007/s00441-020-03173-1

Figure Lengend Snippet: Immunohistochemical staining for extracellular matrix and proliferating cells. CopGFP-expressing HFBSCs in mouse brain sections exhibited native fluorescence (a, b, and c; copGFP protein; green). Additionally, sections were stained for Luc2 (a′, b′, and c′; red). The surrounding area of some HFBSCs stained for fibronectin (a″; gray). The vicinity of transplanted HFBSCs stained for laminin (b″; gray). Staining for Ki-67 (c″; gray) was negative in sections containing HFBSCs (green/red). Scale bar = 50 μm

Article Snippet: Primary , Luc2 , Mouse , monoclonal , DSHB , DSHB-LUC-2 , Cytoplasm , 25:100 , Luc2-copGFP transduced cells.

Techniques: Immunohistochemical staining, Staining, Expressing, Fluorescence

Overview of staining pattern

Journal: Cell and Tissue Research

Article Title: Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury

doi: 10.1007/s00441-020-03173-1

Figure Lengend Snippet: Overview of staining pattern

Article Snippet: Primary , Luc2 , Mouse , monoclonal , DSHB , DSHB-LUC-2 , Cytoplasm , 25:100 , Luc2-copGFP transduced cells.

Techniques: Staining, Cell Culture, Expressing, Migration, Cell Attachment Assay

Levels of inflammatory markers measured in plasma of sham and 1.5 × 10 6 ·ml −1 of  MRMT‐1/Luc2‐bearing  animals

Journal: British Journal of Pharmacology

Article Title: The nociceptin/orphanin FQ receptor system as a target to alleviate cancer‐induced bone pain in rats: Model validation and pharmacological evaluation

doi: 10.1111/bph.14899

Figure Lengend Snippet: Levels of inflammatory markers measured in plasma of sham and 1.5 × 10 6 ·ml −1 of MRMT‐1/Luc2‐bearing animals

Article Snippet: The rat mammary gland carcinoma cell line, MRMT‐1 (Tohoku University, JP; TKG Cat# TKG 0132, RRID:CVCL_5156), was transfected with the luciferase (Luc2) gene (Trenzyme, Life Science Services, DE) to allow monitoring of cell presence and tumour growth over time.

Techniques: Clinical Proteomics, Marker

Gene expression of oprl1 in dorsal root ganglion (DRG) and bone marrow, measured 21 days post‐surgery in sham and 1.5 × 10 6 ·ml −1 of  MRMT‐1/Luc2‐bearing  animals

Journal: British Journal of Pharmacology

Article Title: The nociceptin/orphanin FQ receptor system as a target to alleviate cancer‐induced bone pain in rats: Model validation and pharmacological evaluation

doi: 10.1111/bph.14899

Figure Lengend Snippet: Gene expression of oprl1 in dorsal root ganglion (DRG) and bone marrow, measured 21 days post‐surgery in sham and 1.5 × 10 6 ·ml −1 of MRMT‐1/Luc2‐bearing animals

Article Snippet: The rat mammary gland carcinoma cell line, MRMT‐1 (Tohoku University, JP; TKG Cat# TKG 0132, RRID:CVCL_5156), was transfected with the luciferase (Luc2) gene (Trenzyme, Life Science Services, DE) to allow monitoring of cell presence and tumour growth over time.

Techniques: Gene Expression

Effect of 1.25 × 10 6 ·ml −1 of MRMT‐1/Luc2 inoculated cells on (a) weight‐bearing ratio, (b) cold allodynia, and (c) mechanical allodynia, including the effect of i.p. morphine (3.16 mg·kg −1 ) administration. All data are presented as mean ± SEM; n = 9, all MRMT‐1/Luc2‐bearing animals; * P < .05 versus pretest

Journal: British Journal of Pharmacology

Article Title: The nociceptin/orphanin FQ receptor system as a target to alleviate cancer‐induced bone pain in rats: Model validation and pharmacological evaluation

doi: 10.1111/bph.14899

Figure Lengend Snippet: Effect of 1.25 × 10 6 ·ml −1 of MRMT‐1/Luc2 inoculated cells on (a) weight‐bearing ratio, (b) cold allodynia, and (c) mechanical allodynia, including the effect of i.p. morphine (3.16 mg·kg −1 ) administration. All data are presented as mean ± SEM; n = 9, all MRMT‐1/Luc2‐bearing animals; * P < .05 versus pretest

Article Snippet: The rat mammary gland carcinoma cell line, MRMT‐1 (Tohoku University, JP; TKG Cat# TKG 0132, RRID:CVCL_5156), was transfected with the luciferase (Luc2) gene (Trenzyme, Life Science Services, DE) to allow monitoring of cell presence and tumour growth over time.

Techniques:

(a) The effect of nociceptin (i.t.) and morphine (i.t.) and (b) the effect of systemic Ro65‐6570 (i.p.; NOP receptor agonist) and morphine (i.p.) on mechanical allodynia in 1.5 × 10 6 ·ml −1 of MRMT‐1/Luc2‐bearing animals in the von Frey test. (c) The effect of Ro65‐6570 (i.p.) is blocked by the NOP receptor antagonist J‐113397 (i.p.). All data are presented as mean ± SEM; n = 7 sham, n = 8 vehicle, n = 7 morphine, n = 8 nociceptin 1 μg, n = 8 nociceptin 3 μg, n = 6 nociceptin 10 μg in (a); n = 9 sham, n = 8 vehicle, n = 6 morphine, n = 7 Ro65‐6570 0.3 mg·kg −1 , n = 6 Ro65‐6570 1.0 mg·kg −1 , n = 5 Ro65‐6570 2.15 mg·kg −1 in (b); n = 9 vehicle, n = 8 Ro65‐6570, n = 8 J‐113397, n = 10 Ro65‐6570 + J‐113397 in (c); * P < .05 versus vehicle

Journal: British Journal of Pharmacology

Article Title: The nociceptin/orphanin FQ receptor system as a target to alleviate cancer‐induced bone pain in rats: Model validation and pharmacological evaluation

doi: 10.1111/bph.14899

Figure Lengend Snippet: (a) The effect of nociceptin (i.t.) and morphine (i.t.) and (b) the effect of systemic Ro65‐6570 (i.p.; NOP receptor agonist) and morphine (i.p.) on mechanical allodynia in 1.5 × 10 6 ·ml −1 of MRMT‐1/Luc2‐bearing animals in the von Frey test. (c) The effect of Ro65‐6570 (i.p.) is blocked by the NOP receptor antagonist J‐113397 (i.p.). All data are presented as mean ± SEM; n = 7 sham, n = 8 vehicle, n = 7 morphine, n = 8 nociceptin 1 μg, n = 8 nociceptin 3 μg, n = 6 nociceptin 10 μg in (a); n = 9 sham, n = 8 vehicle, n = 6 morphine, n = 7 Ro65‐6570 0.3 mg·kg −1 , n = 6 Ro65‐6570 1.0 mg·kg −1 , n = 5 Ro65‐6570 2.15 mg·kg −1 in (b); n = 9 vehicle, n = 8 Ro65‐6570, n = 8 J‐113397, n = 10 Ro65‐6570 + J‐113397 in (c); * P < .05 versus vehicle

Article Snippet: The rat mammary gland carcinoma cell line, MRMT‐1 (Tohoku University, JP; TKG Cat# TKG 0132, RRID:CVCL_5156), was transfected with the luciferase (Luc2) gene (Trenzyme, Life Science Services, DE) to allow monitoring of cell presence and tumour growth over time.

Techniques: